Thromb Haemost 1996; 76(04): 627-628
DOI: 10.1055/s-0038-1650633
Letters to the Editor
Schattauer GmbH Stuttgart

Resistance to Activated Protein C in Adults with a History of Juvenile Transient Ischemic Attacks

D De Lucia
1   Institute of General Pathology and Oncology, II University of Naples, Italy
,
A M Cerbone
3   Institute of Internal Medicine, University Federico II of Naples, Italy
,
A Belli
1   Institute of General Pathology and Oncology, II University of Naples, Italy
,
C Di Mauro
1   Institute of General Pathology and Oncology, II University of Naples, Italy
,
V Renis
1   Institute of General Pathology and Oncology, II University of Naples, Italy
,
M Conte
1   Institute of General Pathology and Oncology, II University of Naples, Italy
,
R Rocino
2   Hematology Division, Haemophilia and Thtombosis Center, Pellegrini Hospital, Naples, Italy
,
M L Papa
2   Hematology Division, Haemophilia and Thtombosis Center, Pellegrini Hospital, Naples, Italy
,
R de Biasi
2   Hematology Division, Haemophilia and Thtombosis Center, Pellegrini Hospital, Naples, Italy
› Author Affiliations
Further Information

Publication History

Received 07 June 1996

Accepted after resubmission 21 June 1996

Publication Date:
10 July 2018 (online)

 
  • References

  • 1 Dahlback B. Protein S and C4b-Binding Protein: Components involved in the regulation of the protein C anticoagulant system. Thromb Haemost 1991; 66: 49-61
  • 2 Malm J, Laurell M, Nilsson IM, Dahlback B. Thromboembolic disease-critical evaluation of laboratory investigation. Thromb Haemost 1992; 68 (01) 7-13
  • 3 Svensson PJ, Dahlback B. Resistance to activate protein C as a basis for venous thrombosis. N Eng J Med 1994; 330 (08) 517-22
  • 4 Dahlback B. Inherited resistance to activated protein C, a major cause of venous thrombosis, is due to a mutation in the factor V gene. Haemostasis 1994; 24: 139-151
  • 5 Majerus PW. Bad blood by mutation. Nature 1994; 369: 14-15
  • 6 Ridker PM, Hennekens CH, Linpaintner K, Stampfer MJ, Eisenberg PR, Miletich J. Mutation in the gene coding for coagulation factor V and the risk of myocardial infarction, stroke and venous thrombosis in apparently healthy men. N Eng J Med 1995; 332 (14) 912-917
  • 1 Bertina RM, Koeleman BPC, Koster T, Rosendaal FR, Dirven RJ, de Ronde H, van der Velden PA, Reitsma PH. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 1994; 369: 64-67